New hair loss gel enters human safety testing
NCT ID NCT06927960
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tested the safety of a new topical gel called AH-001 in 64 healthy volunteers and men with male pattern baldness. Participants received either a single dose or daily doses for a week of the gel or a placebo. The study focused on side effects and how the drug moves through the body, not on hair regrowth.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AH-001 topical gel
- What this could lead to
- If safe, this could lead to a new topical treatment for male pattern baldness that helps regrow hair.
- What could go wrong
- This is an early Phase 1 safety trial with only 64 people. It does not test if AH-001 actually works for hair loss, and side effects are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Altasciences Clinical Los Angeles, Inc.
Los Angeles, California, 90630, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tiny needles boost hair growth in balding men?
- A battle for your hair: herbal oil vs. minoxidil serum in a Head-to-Head trial
- Can light boost PRP's power against hair loss?
- Hair loss linked to gut and scalp bacteria in new study
- Baldness breakthrough? own cells injected into scalp to regrow hair
- New laser could spark hair regrowth in balding patients